alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT
      10.8

     

    Form
      of Employment Agreement

    


    This
      Employment Agreement (this “Agreement”) is made by Duoyuan Digital Printing
      Technology Industry (China) Co., Ltd. (the “Company’) and __________________
      (the “Employee”).  The duration of the employment is one year, which shall
      end on December 25 of each year and is renewable upon notice from the Employee
      and consent of the Company.  After ten years of continuous employment, the
      Employee may enter into an employment agreement with the Company for an
      indefinite period of time, subject to the Company’s consent. 

     

    The
      Company shall pay for all mandatory social security programs such as pension
      insurances, unemployment insurances and medical insurances of the Employee
      according to the relevant government and city regulations.  During the term
      of this Agreement, the Employee’s welfare shall be implemented in accordance
      with the laws and relevant regulations of the People’s Republic of
      China.

     

    The
      Employee shall comply with the management’s directions of the Company and comply
      with the bylaws and labor disciplines of the Company.  All intellectual
      property rights the Employee obtains during the term of employment shall belong
      to, and be the property of, the Company.  The Employee shall undertake an
      obligation to keep and not to disclose any trade secrets of the Company during
      the term of this Agreement.

     

    The
      Company may terminate this Agreement for cause, without notice or
      severance.  The Company may also terminate this Agreement upon 30 days’
notice if the Employee is not suitable for the job due to medical or other
      reasons.  If the Company lays off the Employee because of an economic
      downturn or terminates an employee because the Employee is not suitable for
      the
      job or is not able to work due to sickness or injury, the Company shall pay
      up
      to 12 months’ salary as severance.  The Employee may terminate this
      Agreement without cause upon one month’s notice or for cause without
      notice.
|   | (a)                                             |   | the      Quarterly Report on Form 10-Q of the Company for the quarter ended March      31, 2010 filed on the date hereof with the Securities and Exchange      Commission (the “Report”) fully complies with the requirements of Section      13(a) or 15(d) of the Securities Exchange Act of 1934;  and |
|--------|-------------------------------------------------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                            |   |                                                                                                                                                                                                                                                                                                                  |
|   | (b)                                             |   | the      information contained in the Quarterly Report fairly presents, in all      material respects, the financial condition and results of operations of      the Company.                                                                                                                                         |
|   |                                            |   |                                                                                                                                                                                                                                                                                                                  |   |
|   |                                            |   |
|   | /s/ David W.      Thompson                      |   |
|   | David      W. Thompson                     |   |
|   | Chairman      and Chief Executive Officer  |   |
|   | April      23, 2010                        |   |
|   |
**EXHIBIT23.1**

 

**INDEPENDENT****AUDITORS****’****CONSENT**

 

We consent to theincorporation by reference in Registration Statement Nos. 33-84226, 33-80858,and 333-29299 of Full House Resorts, Inc. on Form S-8 of our report datedFebruary 15, 2003 appearing in this Annual Report on Form 10-KSB of Full HouseResorts, Inc. for the year ended December 31, 2002.

 
| DELOITTE &  TOUCHE LLP |
|----------------------------|
|                       |
| Las Vegas, Nevada          |
| March 25, 2003             |

 

----
Michigan Supreme Court Lansing, Michigan

Stephen J. Markman,
Chief Justice

Brian K. Zahr a Bridget M. McCormac k

David F. Viviano

Richard H. Bernstei n Kurtis T. Wilde r Elizabeth T. Clement,

J ustices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the foregoing is a true and complete copy of the order entered at t he direction of the Court.

May 25, 2018

s0522 

# Order

Clerk May 25, 2018

157319

PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellant,

v SC: 15 7319 COA: 333988 Kalamazoo CC: 2015-001179-FC

KEVIN DEANDRE WARE, Defendant-Appellee.

________________ _______________ __________/

On order of the Court, the application for leave to appeal the January 9, 2018 judgment of the Court of Appeals is considered, and it is DENIE D, because we are not persuaded that the question pres ented should be reviewed by thi s Court.
THE THIRTEENTH COURT OF APPEALS

13-19-00314-CR

Ismael Miranda Jr.

v.

The State of Texas

On Appeal from the

138th District Court of Cameron County, Texas

Trial Court Cause No. 2012-DCR-2943-B

JUDGMENT

THE THIRTEENTH COURT OF APPEALS, having considered this cause on 

appeal, concludes that the judgment of the trial court should be affirmed. The Court 

orders the judgment of the trial court AFFIRMED.

We further order this decision certified below for observance.

August 20, 2020
<PAGE>

                                                                    EXHIBIT 32.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO SECTION 906
                        OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Wolverine Tube, Inc. on Form 10-Q for
the period ending September 28, 2003 as filed with the Securities and Exchange
Commission on the date hereof (the "Report"), I, Dennis J. Horowitz, Chief
Executive Officer of Wolverine Tube, Inc., certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that to the best of my knowledge and belief:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities and Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

A signed original of this written statement required by Section 906 has been
provided to Wolverine Tube, Inc. and will be retained by Wolverine Tube, Inc.
and furnished to the Securities and Exchange Commission or its staff upon
request.

/s/ Dennis J. Horowitz

Dennis J. Horowitz
Chief Executive Officer
November 12, 2003
II 

111TH CONGRESS 

1ST SESSION S. 2562 

To extend the temporary suspension of duty on MCPB Acid and MCPB 

Sodium Salt. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 30, 2009 

Mr. BURRIS introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on MCPB Acid 

and MCPB Sodium Salt. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. MCPB ACID AND MCPB SODIUM SALT. 

4 (a) IN GENERAL.—Heading 9902.22.94 of the Har5 monized Tariff Schedule of the United States (relating to 

6 MCPB Acid and MCPB Sodium Salt) is amended by 

7 striking the date in the effective period column and insert8 ing ‘‘12/31/2011’’. 

9 (b) EFFECTIVE DATE.—The amendment made by 

10 subsection (a) applies to goods entered, or withdrawn from 


smartinez on DSKB9S0YB1PROD with BILLS
2 

•S 2562 IS

1 warehouse for consumption, on or after the 15th day after 

2 the date of the enactment of this Act. 

Æ 


smartinez on DSKB9S0YB1PROD with BILLS
IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 16-10174

Conference Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee

v.

JAMES GATLIN,

Defendant-Appellant

Appeal from the United States District Court

for the Northern District of Texas

USDC No. 4:15-CR-152-2

Before JONES, DENNIS, and GRAVES, Circuit Judges.

PER CURIAM:*

The attorney appointed to represent James Gatlin has moved for leave 

to withdraw and has filed a brief in accordance with Anders v. California, 386 

U.S. 738 (1967), and United States v. Flores, 632 F.3d 229 (5th Cir. 2011). 

Gatlin has not filed a response. We have reviewed counsel’s brief and the 

relevant portions of the record reflected therein. We concur with counsel’s 

assessment that the appeal presents no nonfrivolous issue for appellate review. 

 

* Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not 

be published and is not precedent except under the limited circumstances set forth in 5TH 

CIR. R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

December 20, 2017

Lyle W. Cayce

Clerk

 Case: 16-10174 Document: 00514279348 Page: 1 Date Filed: 12/20/2017
No. 16-10174

2

Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is 

excused from further responsibilities herein, and the APPEAL IS DISMISSED. 

See 5TH CIR. R. 42.2.

 Case: 16-10174 Document: 00514279348 Page: 2 Date Filed: 12/20/2017
EXHIBIT 32.2



CERTIFICATION PURSUANT TO

18 U.S.C.
SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Columbia Laboratories, Inc. (the Company) on Form 10-Q for the period ended June 30, 2003 as filed with the Securities and Exchange Commission on the date hereof
(the Report), I, David L. Weinberg, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:



| | (1) |  | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- |  | ---------------------------------------------------------------------------------------------------------------------



| | (2) |  | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| | --- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------



/s/    David L. Weinberg

David L. Weinberg

Chief Financial Officer

August 14, 2003
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                       6,530,838
<SECURITIES>                                         0
<RECEIVABLES>                                1,955,091
<ALLOWANCES>                                    97,276
<INVENTORY>                                    980,010
<CURRENT-ASSETS>                             9,542,626
<PP&E>                                       2,471,182
<DEPRECIATION>                               1,150,430
<TOTAL-ASSETS>                              13,555,840
<CURRENT-LIABILITIES>                        4,543,714
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                         31
<COMMON>                                       280,576
<OTHER-SE>                                   8,625,494
<TOTAL-LIABILITY-AND-EQUITY>                13,555,840
<SALES>                                      3,731,348
<TOTAL-REVENUES>                             3,731,348
<CGS>                                        2,070,992
<TOTAL-COSTS>                                2,070,992
<OTHER-EXPENSES>                            12,764,788
<LOSS-PROVISION>                               (8,162)
<INTEREST-EXPENSE>                              15,819
<INCOME-PRETAX>                            (8,808,862)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (8,808,862)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (8,808,862)
<EPS-PRIMARY>                                    (.32)
<EPS-DILUTED>                                    (.32)
        

</TABLE>
## Breadcrumb

-  Home 
-  About Grants 
-  Programs 

# Tribal Colleges Extension Program

###### Share

Print FriendlyEmailTwitterFacebook

              -  NIFA Tribal Programs                   -  New Beginning for Tribal Students (NBTS) 
                -  Tribal Equity Grants Program 
                -  Tribal Colleges Extension Program 
                -  Tribal College Research Grant Program 
                -  Federally-Recognized Tribes Extension Program 

This grant supports community-based education at the federally recognized tribal colleges. Through this funding, the 1994 Land-Grants touch the lives of reservation youth, farmers and families with activities that enhance health, promote prosperity and support learning. 

The Tribal College Extension grant program allows the 1994 Land-Grants to create extension offices for their reservation communities. Each extension office works with reservation communities to build programs that target local needs. The result is a diversified and targeted outreach. Reservation youth participate in fun activities in a safe environment. Farmers and ranchers gain science-based insights to improve their productivity.

Financial literacy training enhances rural reservation economies. The 1994 Land-Grants also provide culture-centered family activities to restore Native languages, traditions and agriculture. Within this grant program are two types of funds: Capacity grants and Special Emphasis. Capacity grants fund an entire Extension office which can have many mission areas and clients. Special Emphasis are targeted, short-term pilot projects that allow Extension educators to explore new ways to better serve their community.

#### Webinars:

                  - Tribal Colleges Extension Program Capacity and Special Emphasis Webinar   (recorded May 19, 2022)

#### Funding Opportunity:

                  - Tribal Colleges Extension Program - Capacity Applications

#### Program Specialists

                  - Ara Staab
                  - Prali Chitnis

Janyce Woodard

Institutional Review Board (IRB) for Tribal Schools

Tribal Colleges Extension Program: Special Emphasis

Education

Minority Serving Institutions
This disposition is not appropriate for publication and is not precedent *

except as provided by 9th Cir. R. 36-3.

The panel unanimously concludes this case is suitable for decision **

without oral argument. See Fed. R. App. P. 34(a)(2).

NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

UNITED STATES OF AMERICA,

 Plaintiff - Appellee,

 v.

ROBERTO SOLIS-CABRALLES, a.k.a.

David Contreras, a.k.a. Javier Zasueta,

 Defendant - Appellant.

No. 12-10316

D.C. No. 2:11-cr-00265-KJM

MEMORANDUM*

Appeal from the United States District Court

for the Eastern District of California

Kimberly J. Mueller, District Judge, Presiding

Submitted June 18, 2013** 

Before: TALLMAN, M. SMITH, and HURWITZ, Circuit Judges. 

Roberto Solis-Cabralles appeals from the district court’s judgment and

challenges the 77-month sentence imposed following his jury-trial conviction for

two counts of being a deported alien found in the United States, in violation of 8

FILED

JUN 21 2013

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 12-10316

U.S.C. § 1326. We have jurisdiction under 28 U.S.C. § 1291, and we affirm.

Solis-Cabralles contends that the district court erred by denying him a twolevel downward adjustment for acceptance of responsibility under U.S.S.G.

§ 3E1.1(a), because his pre-trial statements demonstrated his acceptance of

responsibility. The parties dispute the standard of review that applies to this claim. 

Contrary to Solis-Cabralles’s argument, the district court did not misapprehend the

law with respect to the adjustment for acceptance of responsibility. We therefore

review the district court’s finding that Solis-Cabralles did not accept responsibility

for his offense for clear error. See United States v. Garrido, 596 F.3d 613, 617

(9th Cir. 2010).

The district court considered Solis-Cabralles’s pre-trial statements but

denied the adjustment based on the record as a whole, including Solis-Cabralles’s

conflicting statements to immigration authorities and his suggestion that his

presence in the United States was involuntary. The district court did not clearly err

in denying the adjustment. See United States v. Molina, 596 F.3d 1166, 1169-70

(9th Cir. 2013).

AFFIRMED.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          OCT-31-1997
<PERIOD-START>                             NOV-01-1996
<PERIOD-END>                               APR-30-1997
<CASH>                                           5,854
<SECURITIES>                                         0
<RECEIVABLES>                                    1,564
<ALLOWANCES>                                         0
<INVENTORY>                                     22,823
<CURRENT-ASSETS>                                30,387
<PP&E>                                           5,576
<DEPRECIATION>                                   1,231
<TOTAL-ASSETS>                                  35,034
<CURRENT-LIABILITIES>                           17,178
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            75
<OTHER-SE>                                      15,468
<TOTAL-LIABILITY-AND-EQUITY>                    35,034
<SALES>                                         36,833
<TOTAL-REVENUES>                                36,833
<CGS>                                           30,197
<TOTAL-COSTS>                                   30,197
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 695
<INCOME-PRETAX>                                  1,229
<INCOME-TAX>                                       477
<INCOME-CONTINUING>                                752
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       752
<EPS-PRIMARY>                                      .10
<EPS-DILUTED>                                      .10
        

</TABLE>
-  Home 
        -  Research & Funding 
        -  Current Funding Opportunities 
        -  Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required) 

View Current Funding Opportunities

# Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)

This Funding Opportunity Announcement encourages the submission of pilot and feasibility clinical trials conducted in humans that will lay the foundation for larger clinical trials related to the prevention and/or treatment of diseases and conditions within the mission of NIDDK. The program will support small, short-term proof-of-concept clinical trials in humans to acquire preliminary data regarding the effects of the intervention, as well as feasibility data related to recruitment and retention, and study conduct. Applications for clinical trials submitted under this FOA should have clearly described aims and objectives, and have a high likelihood that the trial findings will lead to more definitive, hypothesis-driven trials to improve understanding, diagnosis, prevention or treatment of the diseases studied and have the potential to impact clinical practice and/or public health.  Preliminary data regarding intervention efficacy are not required.

### Funding Opportunity Details

Full Announcement:PAS-23-086Related Notices or Announcements:NOT-DK-24-016; NOT-OD-22-195; NOT-OD-22-189; not-od-22-198; NOT-OD-23-012

Program Contacts:Aynur Unalp-Arida, M.D., M.Sc., Ph.D.; Susan Mendley, M.D.; Barbara Linder, M.D., Ph.D.

R01 - Research Project Grant

### Key Dates

Open Date:            5/15/2023        

Letter of Intent Due Date:            Not applicable
[ DO NOT PUBLISH] 

## In the 

# United States Court of Appeals For the Eleventh Circuit

____________________
No. 22

- 11094

Non

- Argument Calendar

____________________

UNITED STATES OF AMERICA,

Plaintiff

- Appellee,

versus OLFAR JULIAN PUERTO ARIAS, a.k.a Puerto,

Defendant

- Appellant.

____________________ Appeal from the United States District Court for the Southern District of Florida D.C. Docket No. 1:18

- cr

- 20236

- JEM

- 1

____________________ USCA11 Case: 22-11094 Document: 29-1 Date Filed: 02/16/2023 Page: 1 of 22 Opinion of the Court 22

- 11094

Before W ILSON , L UCK , and L AGOA , Circuit Judges.

PER CURIAM: The Government’s motion to dismiss this appeal pursuant to the appeal waiver in Appellant’s plea agreement is GRANTED. See United States v. Bushert , 997 F.2d 1343, 1351 (11th Cir. 1993) (sentenc e appeal waiver will be enforced if it was made knowingly and voluntarily); United States v. Boyd , 975 F.3d 1185, 1192 (11th Cir. 2020) (sentence appeal waiver will be enforced where “it was clearly conveyed to the defendant that he was giving up his right to appeal under most circumstances” (quotation marks and brackets omitted)) ; United States v. Howle , 166 F.3d 1166, 1169 & n.5 (11th Cir. 1999) (an appeal waiver may waive difficult or debatable legal issues but could be reviewable in extreme circumstance s)

. USCA11 Case: 22-11094 Document: 29-1 Date Filed: 02/16/2023 Page: 2 of 2